Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner (Q40200264)
Jump to navigation
Jump to search
scientific article published on 5 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner |
scientific article published on 5 December 2006 |
Statements
1 reference
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner (English)
1 reference
1 reference
1 reference
Laurence Lagneaux
1 reference
Virginie Durbecq
1 reference
Jean-François Laes
1 reference
Bassam Badran
1 reference
Françoise Bex
1 reference
Karen Willard-Gallo
1 reference
Jeffrey S Ross
1 reference
Martine Piccart
1 reference
Christos Sotiriou
1 reference
5 December 2006
1 reference
1 reference
3042-3051
1 reference
Identifiers
1 reference